Related references
Note: Only part of the references are listed.Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study
Katherine E. Battle et al.
LANCET (2019)
Plasmodium vivax Controllec Human Malaria Infection - Procress anc Prospects
Ruth O. Payne et al.
TRENDS IN PARASITOLOGY (2017)
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy
Jason W. Bennett et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900
Bilal Ahmad Rahimi et al.
MALARIA JOURNAL (2014)
Plasmodium vivax Sporozoite Challenge in Malaria-Naive and Semi-Immune Colombian Volunteers
Myriam Arevalo-Herrera et al.
PLOS ONE (2014)
Plasmodium vivax malaria vaccines
Arturo Reyes-Sandoval et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion
Joanne M. Lumsden et al.
INFECTION AND IMMUNITY (2011)
CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
Arturo Reyes-Sandoval et al.
JOURNAL OF IMMUNOLOGY (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A biologist's perspective on malaria vaccine development
Robert E. Sinden
HUMAN VACCINES (2010)
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Timothy N. C. Wells et al.
TRENDS IN PARASITOLOGY (2010)
Case Report: Successful Sporozoite Challenge Model in Human Volunteers with Plasmodium vivax Strain Derived from Human Donors
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax
Brian A. Bell et al.
VACCINE (2009)
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Arturo Reyes-Sandoval et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
Emiliana Tjitra et al.
PLOS MEDICINE (2008)
Vivax malaria: Neglected and not benign
Ric N. Price et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
Anjali Yadava et al.
INFECTION AND IMMUNITY (2007)
Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine
S Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Plasmodium vivax:: Recent world expansion and genetic identity to Plasmodium simium
CS Lim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Motility and infectivity of Plasmodium berghei sporozoites expressing avian Plasmodium gallinaceum circumsporozoite protein
R Tewari et al.
CELLULAR MICROBIOLOGY (2005)
Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein
S Herrera et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Share Paper
